Investors Keenly Eye Breakthrough Alzheimer’s Drugs from Pharma Giants

As the pharmaceutical industry continues to push boundaries in the fight against Alzheimer’s disease, investors are closely monitoring the latest advancements from leading companies such as Eli Lilly, Novo Nordisk, and Roche. The heightened interest comes on the heels of a series of clinical trials that have shown promise in tackling this debilitating condition, which currently affects millions worldwide.

Continue reading